Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Ignace Vergote

Niraparib in Patients With Newly Diagnosed Advanced Ovarian Cancer

New England Journal of Medicine

Medicine

2019

English

Neoadjuvant Chemotherapy Versus Debulking Surgery in Advanced Tubo-Ovarian Cancers: Pooled Analysis of Individual Patient Data From the EORTC 55971 and CHORUS Trials

The Lancet Oncology

Oncology

2018

English

Olaparib Tablets as Maintenance Therapy in Patients With Platinum-Sensitive, Relapsed Ovarian Cancer and a BRCA1/2 Mutation (SOLO2/ENGOT-Ov21): A Double-Blind, Randomised, Placebo-Controlled, Phase 3 Trial

The Lancet Oncology

Oncology

2017

English

Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer

Clinical Cancer Research

Cancer Research

Oncology

2019

English

The Dark Side of ID8-Luc2: Pitfalls for Luciferase Tagged Murine Models for Ovarian Cancer

Journal for ImmunoTherapy of Cancer

English

ENGOT-ov-6/TRINOVA-2: Randomised, Double-Blind, Phase 3 Study of Pegylated Liposomal Doxorubicin Plus Trebananib or Placebo in Women With Recurrent Partially Platinum-Sensitive or Resistant Ovarian Cancer

European Journal of Cancer

Cancer Research

Oncology

2017

English

Hyperthermic Intraperitoneal Chemotherapy Does Not Improve Survival in Advanced Ovarian Cancer

English

Tumor Treating Fields in Combination With Paclitaxel in Recurrent Ovarian Carcinoma: Results of the INNOVATE Pilot Study

English

Evaluation of T2-W MR Imaging and Diffusion-Weighted Imaging for the Early Post-Treatment Local Response Assessment of Patients Treated Conservatively for Cervical Cancer: A Multicentre Study

English

Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients With No Evidence of Disease Progression After First-Line Platinum-Based Chemotherapy

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Ignace Vergote

Niraparib in Patients With Newly Diagnosed Advanced Ovarian Cancer

Neoadjuvant Chemotherapy Versus Debulking Surgery in Advanced Tubo-Ovarian Cancers: Pooled Analysis of Individual Patient Data From the EORTC 55971 and CHORUS Trials

Olaparib Tablets as Maintenance Therapy in Patients With Platinum-Sensitive, Relapsed Ovarian Cancer and a BRCA1/2 Mutation (SOLO2/ENGOT-Ov21): A Double-Blind, Randomised, Placebo-Controlled, Phase 3 Trial

Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer

The Dark Side of ID8-Luc2: Pitfalls for Luciferase Tagged Murine Models for Ovarian Cancer

ENGOT-ov-6/TRINOVA-2: Randomised, Double-Blind, Phase 3 Study of Pegylated Liposomal Doxorubicin Plus Trebananib or Placebo in Women With Recurrent Partially Platinum-Sensitive or Resistant Ovarian Cancer

Hyperthermic Intraperitoneal Chemotherapy Does Not Improve Survival in Advanced Ovarian Cancer

Tumor Treating Fields in Combination With Paclitaxel in Recurrent Ovarian Carcinoma: Results of the INNOVATE Pilot Study

Evaluation of T2-W MR Imaging and Diffusion-Weighted Imaging for the Early Post-Treatment Local Response Assessment of Patients Treated Conservatively for Cervical Cancer: A Multicentre Study

Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients With No Evidence of Disease Progression After First-Line Platinum-Based Chemotherapy